SAIC is in a different conversation this week — the earnings shock has landed, the stock has held most of its gains, and the question now is how aggressively the Street re-rates a name it spent the better part of 2026 downgrading.
The analyst response has been swift and directionally consistent. Four separate target-price raises arrived in the 48 hours following the Q1 print. JP Morgan's Seth Seifman lifted his target to $125 from $110, maintaining Neutral — a meaningful acknowledgment that prior caution was too conservative. Citigroup's John Godyn, the most bullish voice on the Street, pushed his Buy target to $132 from $120. UBS moved to $119 from $113, also holding Neutral. Truist raised to $110 from $95 while keeping its Hold. The direction is unanimous: every firm that acted lifted its number. The consensus mean now sits at $117.80, just above the current price of $113.36. That's a tight gap — implying the Street sees limited incremental upside from here at current ratings, even after the revision wave. The sole outlier in the historical record is Goldman Sachs, which cut to a $82 Sell target back in February and has not been heard from since; that figure is almost certainly stale relative to a stock now trading 38% above it.
Short sellers absorbed a brutal week and have barely moved. SI edged fractionally higher over the past five days — up roughly 0.1% — to 6.3% of free float, after falling 1.6% on Tuesday alone as the stock gave back a sliver of its post-earnings spike. The modest daily fluctuation suggests shorts are neither rushing to cover nor adding to a position that is now deeply offside. Borrow conditions offer no forced-hand mechanism: cost to borrow is just 0.54%, barely changed from where it sat pre-earnings, and availability is exceptionally loose at 808% of short interest — roughly eight shares available to borrow for every one currently borrowed. The ORTEX short score has drifted lower to 48.6, off a recent peak above 50, consistent with a modest easing in short conviction rather than any meaningful capitulation.
Options positioning has snapped back sharply after the record-low put/call ratio that defined the pre-earnings setup. The PCR now reads 0.38 — still below its 20-day average of 0.48, but 1.4 standard deviations below rather than the 2.7 standard deviations the pre-print note flagged. The extreme call skew has unwound as the catalyst played out. What remains is a modest tilt toward calls, not conviction-level bullish positioning. Traders who were loading calls ahead of June 1 have largely had their trade resolved.
The peer group offers some useful context on whether the post-earnings move is holding up. BAH, SAIC's closest comparable at 76% correlation, fell 4.4% on Tuesday and is barely positive on the week at +0.5%. KBR gained 6.6% on the week and TNET surged 13.3%, though both carry lower correlations to SAIC's business mix. LDOS dipped 1% on the week. The government services sector is not uniformly strong — SAIC's 11.8% weekly gain is an outlier, reflecting a stock-specific re-rating rather than a broad sector lift.
The next observable question is whether Goldman updates its Sell thesis — the $82 target against a $113 stock is the most visible divergence on the board — and whether any of the Neutral-rated firms upgrade their recommendation to match their higher price targets.
See the live data behind this article on ORTEX.
Open SAIC on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
